Earnings Feed
Start Free
CUBIST PHARMACEUTICALS INC·4

May 17, 3:01 PM ET

Vetticaden Santosh 4

4 · CUBIST PHARMACEUTICALS INC · Filed May 17, 2011

Insider Transaction Report

Form 4
Period: 2011-05-13
CUBIST PHARMACEUTICALS INCCBST
Vetticaden Santosh
SVP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2011-05-14+1,875→ 5,545 total
  • Exercise/Conversion

    Common Stock

    2011-05-15+2,237→ 7,782 total
  • Exercise/Conversion

    Restricted Stock Units

    2011-05-15−2,237→ 4,475 total
    From: 2010-05-15→ Common Stock (2,237 underlying)
  • Award

    Stock Options (Right to Buy)

    2011-05-13+45,000→ 45,000 total
    Exercise: $34.80From: 2011-08-13Exp: 2021-05-13→ Common Stock (45,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2011-05-14−1,875→ 5,625 total
    From: 2011-05-14→ Common Stock (1,875 underlying)
  • Award

    Restricted Stock Units

    2011-05-13+7,200→ 7,200 total
    From: 2012-05-13→ Common Stock (7,200 underlying)
Footnotes (3)
  • [F1]Option vests 6.25% quarterly over a four-year period.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Cubist common stock.
  • [F3]The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24
    doc1.htm

    POWER OF ATTORNEY 1/20/2009 9:55:37 PM